EQS-Adhoc

European Healthcare Acquisition & Growth Company B.V.: Public disclosure of inside information

EQS-Ad-hoc: European Healthcare Acquisition & Growth Company B.V. / Key word(s): Miscellaneous European Healthcare Acquisition & Growth Company B.V.: Public disclosure of inside information 21-Jun-2023 / 09:43 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. NOT FOR DISTRIBUTION, PUBLICATION OR FORWARDING, EITHER DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS PUBLICATION.

Public disclosure of inside information according to Article 17 para. 1 of the Regulation (EU) No 596/2014 on market abuse (Market Abuse Regulation)

European Healthcare Acquisition & Growth Company B.V. and Croma-Pharma GmbH agree on award and transfer of four treasury shares for each ten public shares that public shareholders do not redeem and investors will purchase if reduced minimum net cash condition of EUR 50 million is met and shareholders approve business combination on June 27, 2023

• European Healthcare Acquisition & Growth Company B.V. (EHC) will award and transfer four treasury shares for each ten public shares that public shareholders will not redeem thereby waiving their redemption rights.
• EHC will also transfer four additional treasury shares for each ten treasury shares that public shareholders or new investors will purchase through a private investment in public equity (PIPE).
• EHC Sponsors will devalue another 40% of their class B warrants (Sponsor Warrants).
• Croma-Pharma GmbH (Croma) and the shareholders of Croma (Croma Shareholders) agreed with EHC to reduce the minimum net cash condition from EUR 100 million to EUR 50 million.
• Croma Shareholders and EHC Sponsors will not receive any additional shares or any other incentive.

Munich, June 21, 2023